Skip to content
Gov. Hochul Tours Renovated Feinstein Institutes Bioelectronic Medicine Lab, Announces First $10 Million Award

Manhasset, New York – (work wire)–During a special event, the Feinstein Institutes for Medical Research, home of Northwell Health research, and Governor Cathy Hochhol today announced the completion of a $35 million 20,000 square foot renovation project aimed at reinvigorating future advances in bioelectronic medicine. The state-of-the-art research space at Manhasset was completed by grant funding from the Empire State Development (ESD) in New York. Governor Hochhol also announced a new $10 million ESD grant to the Feinstein Institutes for a second phase of laboratory renovations.

Michael Dowling, CEO of Northwell Health, and Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes, officially unveiled the renovated lab space during a tour with Gov. Hochul, along with Hope Knight, Empire State Development CEO and Commissioner, and Kevin Law, Chairman of the Empire State Development Board. Other esteemed guests at the ceremony included Assemblywoman Gina L. Celiti and Senator Anna M. Kaplan.

“New York is leading the way in medical innovation, and the Long Island Investment Fund will support life-saving research in the cutting edge of the life sciences industry,” said New York Governor Hochhol. “Our investment in the Electronic Biomedical Institute is already improving the lives of New Yorkers every day, and the additional Long Island Investment Fund award announced today underscores our commitment to remaining as a national leader in health and medical research. I am proud of our support of the Feinstein Institutes and its research, which will lead to medical and life-changing treatments that will improve the lives of New Yorkers on Long Island and across the state.”

The Feinstein Institutes, the global scientific home of bioelectronic medicine, consists of 50 research laboratories, 3,000 clinical research studies, and 5,000 researchers and staff. The new lab space will spark ongoing innovative research and recruitment of New York’s brightest medical researchers.

“At Northwell, we strive to improve the health of the communities we serve and are committed to providing high-quality clinical care, educating current and future generations of healthcare professionals, and researching new advances in medicine at the Feinstein Institutes for Medical Research through current and additional support now,” Michael Dowling said. By Governor Hochhol, the Empire State Development Corporation and our generous donors, we will continue to provide the world with scientific insights as we continue our leadership in bioelectronic medicine.”

The renovated laboratory includes 1,385 linear square feet of wet lab benches, 13 private offices, multiple tissue culture rooms, cold storage rooms, shared equipment rooms, fume hoods, 100 workstations for researchers and administrators, meeting rooms, and a break room. Fully furnished. In response to the COVID-19 pandemic, the renovation has also established a Biosafety Level 3 (BSL-3) facility, allowing new research into infectious diseases and other complex viruses.

“Our scientists and staff work day in and day out tirelessly to research and develop new treatments for cancer, diabetes, obesity and lupus, among others, and we continue to lead in bioelectronic research,” said Dr. Tracy. “We are grateful to Governor Hochul and the Empire State Development Corporation for their generous support. We can now hire additional investigators, expand our research capabilities and establish Nassau County and the Feinstein Institutes as a destination for scientific discovery.”

The renovated facility of the Feinstein Institutes will allow the recruitment of 13 new principal investigators and support the recruitment of 100 new staff, including research assistants and administrators. The research will allow the Feinstein Institutes to continue creating companies that generate more jobs and economic growth, including leveraging this research into intellectual property, licensed to the biotechnology, pharmaceutical and medical device industries.

The team that helped design and renovate the space included Suffolk Construction, Vlad Architects and Lizardos Engineers.

“It has been an honor and a privilege to have the Feinstein Institutes entrusted the management of the construction of this state-of-the-art laboratory facility,” said John Fish, Chairman and CEO of Suffolk Construction. “We are particularly proud to present a building that will facilitate life-saving research to treat disease and improve health outcomes while fostering New York’s rapidly expanding life sciences market.”

Also acknowledged at the press conference was Sharon Laodice, a patient from Westbury, New York. Benefited from bioelectronic research at the Feinstein Institutes. After sustaining an injury from a car accident, with the help of bioelectronic medicine, she regained movement and sensation.

The Feinstein Institutes have more than 245 patents in more than 80 distinct areas of technology, and have built more than a dozen biotech startups in the past decade. Feinstein Institutes research studies have been shortlisted in Fast Company’s World Changing Ideas Awards for two consecutive years, and a recent report found that 26 Feinstein Institute researchers are among the world’s top 100,000 cited scientists and Feinstein Institutes research is shared across the science community Global Biomedical by producing more than 1,700 publications in medical journals each year.

About the Feinstein Institutes

Feinstein Institutes for Medical Research It is the home of the Research Institutes of Northwell Health, the largest healthcare provider and private employer in New York State. With 50 research laboratories, 3,000 clinical research studies, and 5,000 researchers and staff, the Feinstein Institutes raise the bar for medical innovation through its five Institutes for Behavioral Sciences, Bioelectronics, Cancer, Health System Sciences, and Molecular Medicine. We are making breakthroughs in genetics, oncology, brain research, mental health, and autoimmunity, and we are a global scientific leader in bioelectronic medicine – a new scientific field with the potential to revolutionize medicine. For more information on how we produce knowledge to treat disease, visit and follow us LinkedIn.

Article appeared %% أولاً على %%CHOF360%%.